Skip to main content
  • Sign in
    Welcome !
    My account
    Logout

CAMDEN NATIONAL CORP (CAC) Stock Forecast 2025 - AI Price Prediction & Analysis

CAMDEN NATIONAL CORP (CAC) AI Stock Price Forecast & Investment Analysis

CAMDEN NATIONAL CORP Stock Price Chart and Technical Analysis

Loading CAMDEN NATIONAL CORP interactive price chart and technical analysis...

CAMDEN NATIONAL CORP (CAC) - Comprehensive Stock Analysis & Investment Research

Deep dive into CAMDEN NATIONAL CORP's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about CAMDEN NATIONAL CORP, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For CAMDEN NATIONAL CORP: CAMDEN NATIONAL CORP operates in the Finance sector, making it an emerging small-cap investment.

CAMDEN NATIONAL CORP (Stock Symbol: CAC) is a leading company in the Finance sector , specifically operating within the National Commercial Banks industry.

The organization employs approximately 580 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing CAMDEN NATIONAL CORP's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For CAMDEN NATIONAL CORP: With $197M in annual revenue and 36.3% net margin, the company demonstrates exceptional profitability.

Annual Revenue: $197 million generating a 36.3% net profit margin .

Market Capitalization: $657 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): 13.0% - Above-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for CAMDEN NATIONAL CORP stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For CAMDEN NATIONAL CORP: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for CAMDEN NATIONAL CORP stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: CAMDEN NATIONAL CORP's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For CAMDEN NATIONAL CORP: Strong free cash flow generation demonstrates solid operational efficiency.

CAMDEN NATIONAL CORP strategically competes in the highly dynamic National Commercial Banks marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company demonstrates robust operational efficiency through strong free cash flow generation of $121 million annually, complemented by impressive -44.5% year-over-year cash flow growth.

CAMDEN NATIONAL CORP (CAC) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for CAMDEN NATIONAL CORP stock analysis.

Loading CAMDEN NATIONAL CORP comprehensive fundamental analysis and insider trading data...

Deep dive into CAMDEN NATIONAL CORP's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if CAMDEN NATIONAL CORP stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For CAMDEN NATIONAL CORP: With a P/E ratio of 12.96, the market sees the stock as potentially undervalued.

P/E Ratio 12.96x
P/B Ratio 1.01x
Market Cap $657M
Dividend Yield 4.46%
EPS $3.17
Book Value/Share $38.54
Revenue/Share $11.67
FCF/Share $1.30
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently CAMDEN NATIONAL CORP converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For CAMDEN NATIONAL CORP: An ROE of 13.0% shows good shareholder value creation.

ROE 13.0%
ROA 1.3%
Net Margin 36.3%
EBT Margin 45.8%
Tax Rate 20.5%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess CAMDEN NATIONAL CORP's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For CAMDEN NATIONAL CORP:

D/E Ratio 0.09x
Financial Leverage 11.24x
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal CAMDEN NATIONAL CORP's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For CAMDEN NATIONAL CORP: Free cash flow of $121M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $123M
Free Cash Flow $121M
Capital Spending $-2M
OCF Growth YoY -44.5%
FCF Growth YoY -46.5%
FCF/Sales 67.0%
CapEx/Sales 1.1%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively CAMDEN NATIONAL CORP uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For CAMDEN NATIONAL CORP: An asset turnover of 0.03x suggests room for improvement in asset utilization.

Asset Turnover 0.03x
Fixed Assets Turnover 4.8x
Understanding Financial Statement Data

What these metrics mean: Key figures from CAMDEN NATIONAL CORP's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For CAMDEN NATIONAL CORP: With annual revenue of $197M, CAMDEN NATIONAL CORP demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $197M
SG&A Expense $35M
Balance Sheet Highlights (% Of Assets)
Cash & Short-term Investments 29%
Total Liabilities 91%
Short-term Debt 1%
Accounts Receivable 0%
Dividend & Shareholder Information
Dividends Per Share $1.68
Payout Ratio 0.5%
Shares Outstanding 17M
Growth Metrics (YoY)
EPS Growth 7.2%

Latest CAMDEN NATIONAL CORP Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting CAMDEN NATIONAL CORP (CAC) stock price and investment outlook.

, source: Mainebiz

Camden National Corp. (Nasdaq: CAC) has completed its acquisition of North Conway, N.H.-based Northway Bank to form a combined institution with assets of $7 billion and 73 branches across Maine and New Hampshire. The all-stock deal, valued at $86.6 ...

, source: Insider Monkey

Operator: Good day, and welcome to Camden National Corporation's First Quarter 2024 Earnings Conference Call. My name is Seb, and I'll be your operator for today's call. [Operator Instructions]. Camden National Corporation reports earnings inline with ...

CAMDEN NATIONAL CORP Competitors & Peer Analysis - Finance Sector

Comparative analysis of CAMDEN NATIONAL CORP against industry peers and competitors in the Finance sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ALRS Unlock Forecast - 30 Days FREE Trial $531M 14.2x 1.0x
AMJB Unlock Forecast - 30 Days FREE Trial $80000M 1.4x 0.2x
AMTB Unlock Forecast - 30 Days FREE Trial $720M 200.7x 0.8x
AROW Unlock Forecast - 30 Days FREE Trial $453M 15.0x 1.1x
ASRV Unlock Forecast - 30 Days FREE Trial $50M 13.5x 0.5x
ATLO Unlock Forecast - 30 Days FREE Trial $185M 13.6x 1.0x
BAC Unlock Forecast - 30 Days FREE Trial $394367M 13.9x 1.3x
BAC-PB Unlock Forecast - 30 Days FREE Trial $189784M 6.8x 0.6x
BAC-PE Unlock Forecast - 30 Days FREE Trial $160037M 5.7x 0.5x
BAC-PK Unlock Forecast - 30 Days FREE Trial $185694M 6.6x 0.6x
BAC-PL Unlock Forecast - 30 Days FREE Trial $9450160M 336.6x 31.5x
BAC-PM Unlock Forecast - 30 Days FREE Trial $170672M 6.1x 0.6x
BAC-PN Unlock Forecast - 30 Days FREE Trial $160037M 5.7x 0.5x
BAC-PO Unlock Forecast - 30 Days FREE Trial $136984M 4.9x 0.5x
BAC-PP Unlock Forecast - 30 Days FREE Trial $129621M 4.6x 0.4x
BAC-PQ Unlock Forecast - 30 Days FREE Trial $135050M 4.8x 0.5x
BAC-PS Unlock Forecast - 30 Days FREE Trial $151708M 5.4x 0.5x
BACRP Unlock Forecast - 30 Days FREE Trial $1623055M 57.8x 5.4x
BANC Unlock Forecast - 30 Days FREE Trial $2497M 16.9x 0.7x
BANC-PF Unlock Forecast - 30 Days FREE Trial $3646M 24.7x 1.1x
BANF Unlock Forecast - 30 Days FREE Trial $3642M 16.1x 2.1x
BANFP Unlock Forecast - 30 Days FREE Trial $871M 3.7x 0.5x
BCAL Unlock Forecast - 30 Days FREE Trial $590M 38.9x 1.1x
BFC Unlock Forecast - 30 Days FREE Trial $1237M 18.7x 2.0x
BHRB Unlock Forecast - 30 Days FREE Trial $912M 8.9x 1.2x
BML-PG Unlock Forecast - 30 Days FREE Trial $152526M 5.4x 0.5x
BML-PH Unlock Forecast - 30 Days FREE Trial $151560M 5.4x 0.5x
BML-PJ Unlock Forecast - 30 Days FREE Trial $156319M 5.6x 0.5x
BML-PL Unlock Forecast - 30 Days FREE Trial $152080M 5.4x 0.5x
BOKF Unlock Forecast - 30 Days FREE Trial $8165M 15.3x 1.4x
C Unlock Forecast - 30 Days FREE Trial $191059M 13.0x 0.9x
CAC Unlock Forecast - 30 Days FREE Trial $657M 13.0x 1.0x
CARE Unlock Forecast - 30 Days FREE Trial $391M 13.3x 1.0x
CASH Unlock Forecast - 30 Days FREE Trial $1616M 26.1x 2.0x
CBNA Unlock Forecast - 30 Days FREE Trial $205M 14.7x 1.3x
CBNK Unlock Forecast - 30 Days FREE Trial $465M 11.4x 1.2x
CBU Unlock Forecast - 30 Days FREE Trial $2960M 15.6x 1.6x
CFBK Unlock Forecast - 30 Days FREE Trial $151M 8.4x 0.9x
CFNB Unlock Forecast - 30 Days FREE Trial $231M 46.5x 1.2x
CFR Unlock Forecast - 30 Days FREE Trial $7812M 13.2x 1.9x
CFR-PB Unlock Forecast - 30 Days FREE Trial $1154M 1.9x 0.3x
CHCO Unlock Forecast - 30 Days FREE Trial $1722M 14.6x 2.3x
CMA Unlock Forecast - 30 Days FREE Trial $10057M 14.3x 1.3x
CMTV Unlock Forecast - 30 Days FREE Trial $136M 17.9x 1.3x
COF Unlock Forecast - 30 Days FREE Trial $139658M 16.5x 1.3x
COF-PI Unlock Forecast - 30 Days FREE Trial $12854M x 0.1x
COF-PJ Unlock Forecast - 30 Days FREE Trial $12317M x 0.1x
COF-PK Unlock Forecast - 30 Days FREE Trial $11844M x 0.1x
COF-PL Unlock Forecast - 30 Days FREE Trial $11313M x 0.1x
COF-PN Unlock Forecast - 30 Days FREE Trial $11217M x 0.1x
C-PN Unlock Forecast - 30 Days FREE Trial $59098M 4.2x 0.3x
DCOM Unlock Forecast - 30 Days FREE Trial $1149M 27.7x 0.8x
DCOMG Unlock Forecast - 30 Days FREE Trial $1152M 26.1x 0.8x
DCOMP Unlock Forecast - 30 Days FREE Trial $832M 18.9x 0.6x
ENBP Unlock Forecast - 30 Days FREE Trial $112M 6.5x 0.8x
FCF Unlock Forecast - 30 Days FREE Trial $1625M 12.9x 1.1x
FDBC Unlock Forecast - 30 Days FREE Trial $258M 10.9x 1.2x
FFBC Unlock Forecast - 30 Days FREE Trial $2255M 9.8x 0.9x
FHN Unlock Forecast - 30 Days FREE Trial $10872M 12.8x 1.2x
FHN-PC Unlock Forecast - 30 Days FREE Trial $12988M 15.4x 1.5x
FHN-PE Unlock Forecast - 30 Days FREE Trial $12838M 15.2x 1.4x
FHN-PF Unlock Forecast - 30 Days FREE Trial $9471M 11.2x 1.1x
FIISO Unlock Forecast - 30 Days FREE Trial $2577M x 4.3x
FISI Unlock Forecast - 30 Days FREE Trial $584M 8.1x 1.0x
FMCB Unlock Forecast - 30 Days FREE Trial $732M 8.2x 1.2x
FNB Unlock Forecast - 30 Days FREE Trial $5618M 11.9x 0.9x
FNLC Unlock Forecast - 30 Days FREE Trial $277M 9.6x 1.0x
FRME Unlock Forecast - 30 Days FREE Trial $2041M 9.5x 0.9x
FRMEP Unlock Forecast - 30 Days FREE Trial $1503M 6.7x 0.6x
FSUN Unlock Forecast - 30 Days FREE Trial $926M 12.7x 0.8x
FULT Unlock Forecast - 30 Days FREE Trial $3222M 10.2x 1.0x
FULTP Unlock Forecast - 30 Days FREE Trial $3634M 11.2x 1.1x
FUNC Unlock Forecast - 30 Days FREE Trial $242M 10.2x 1.3x
GNTY Unlock Forecast - 30 Days FREE Trial $553M 15.3x 1.7x
HAFC Unlock Forecast - 30 Days FREE Trial $811M 12.5x 1.1x
HBAN Unlock Forecast - 30 Days FREE Trial $22358M 11.1x 1.0x
HBANL Unlock Forecast - 30 Days FREE Trial $36835M 17.5x 1.8x
HBANM Unlock Forecast - 30 Days FREE Trial $33844M 16.0x 1.6x
HBANP Unlock Forecast - 30 Days FREE Trial $26696M 12.7x 1.3x
HOPE Unlock Forecast - 30 Days FREE Trial $1380M 33.0x 0.6x
HWBK Unlock Forecast - 30 Days FREE Trial $210M 10.2x 1.3x
JPM Unlock Forecast - 30 Days FREE Trial $869217M 14.9x 2.4x
JPM-PC Unlock Forecast - 30 Days FREE Trial $71882M 1.3x 0.2x
JPM-PD Unlock Forecast - 30 Days FREE Trial $70618M 1.3x 0.2x
JPM-PJ Unlock Forecast - 30 Days FREE Trial $59242M 1.1x 0.2x
JPM-PK Unlock Forecast - 30 Days FREE Trial $56573M 1.0x 0.2x
JPM-PL Unlock Forecast - 30 Days FREE Trial $57416M 1.0x 0.2x
JPM-PM Unlock Forecast - 30 Days FREE Trial $53708M 1.0x 0.2x
KEY Unlock Forecast - 30 Days FREE Trial $19380M 112.5x 1.0x
KEY-PI Unlock Forecast - 30 Days FREE Trial $27747M 157.7x 1.4x
KEY-PJ Unlock Forecast - 30 Days FREE Trial $24615M 139.9x 1.3x
KEY-PK Unlock Forecast - 30 Days FREE Trial $24582M 139.7x 1.3x
KEY-PL Unlock Forecast - 30 Days FREE Trial $27758M 157.7x 1.4x
LARK Unlock Forecast - 30 Days FREE Trial $152107M 9321.4x 1025.1x
LCNB Unlock Forecast - 30 Days FREE Trial $207M 9.8x 0.8x
MER-PK Unlock Forecast - 30 Days FREE Trial $192387M 6.9x 0.6x
MFG Unlock Forecast - 30 Days FREE Trial $16953M x 0.0x
MRBK Unlock Forecast - 30 Days FREE Trial $173M 9.5x 1.0x
MZHOF Unlock Forecast - 30 Days FREE Trial $75377M x 0.0x
NBHC Unlock Forecast - 30 Days FREE Trial $1353M 11.9x 1.0x
NBTB Unlock Forecast - 30 Days FREE Trial $1952M 15.0x 1.1x
NEWT Unlock Forecast - 30 Days FREE Trial $267M 5.5x 0.9x
NEWTG Unlock Forecast - 30 Days FREE Trial $658M 12.3x 2.1x
NEWTH Unlock Forecast - 30 Days FREE Trial $652M 12.2x 2.1x
NEWTI Unlock Forecast - 30 Days FREE Trial $665M 12.5x 2.1x
NEWTZ Unlock Forecast - 30 Days FREE Trial $653M 12.2x 2.1x
NIC Unlock Forecast - 30 Days FREE Trial $1717M 13.7x 1.4x
NKSH Unlock Forecast - 30 Days FREE Trial $186M 16.5x 1.1x
NWBI Unlock Forecast - 30 Days FREE Trial $1498M 11.2x 0.9x
OCFC Unlock Forecast - 30 Days FREE Trial $1089M 12.3x 0.7x
ONB Unlock Forecast - 30 Days FREE Trial $7851M 14.2x 0.9x
ONBPO Unlock Forecast - 30 Days FREE Trial $9854M 17.4x 1.2x
ONBPP Unlock Forecast - 30 Days FREE Trial $9817M 17.3x 1.2x
OPHC Unlock Forecast - 30 Days FREE Trial $46M 3.2x 0.4x
PFIS Unlock Forecast - 30 Days FREE Trial $471M 14.3x 1.0x
PNFP Unlock Forecast - 30 Days FREE Trial $6544M 11.5x 1.0x
PNFPP Unlock Forecast - 30 Days FREE Trial $1947M 3.3x 0.3x
PRK Unlock Forecast - 30 Days FREE Trial $2462M 15.5x 2.3x
RF Unlock Forecast - 30 Days FREE Trial $21901M 10.7x 1.2x
RF-PC Unlock Forecast - 30 Days FREE Trial $22127M 10.7x 1.2x
RF-PE Unlock Forecast - 30 Days FREE Trial $16571M 8.0x 0.9x
RF-PF Unlock Forecast - 30 Days FREE Trial $22969M 11.1x 1.2x
SFNC Unlock Forecast - 30 Days FREE Trial $2175M 14.1x 0.6x
SFST Unlock Forecast - 30 Days FREE Trial $363M 16.1x 1.1x
SHBI Unlock Forecast - 30 Days FREE Trial $524M 9.8x 0.9x
SMBK Unlock Forecast - 30 Days FREE Trial $595M 14.5x 1.2x
SNNF Unlock Forecast - 30 Days FREE Trial $19M x 0.8x
SNV Unlock Forecast - 30 Days FREE Trial $6115M 8.1x 1.1x
SNV-PD Unlock Forecast - 30 Days FREE Trial $3495M 4.5x 0.6x
SNV-PE Unlock Forecast - 30 Days FREE Trial $3726M 4.8x 0.7x
STEL Unlock Forecast - 30 Days FREE Trial $1503M 15.0x 0.9x
TBBK Unlock Forecast - 30 Days FREE Trial $3592M 15.5x 4.2x
TRMK Unlock Forecast - 30 Days FREE Trial $2292M 10.8x 1.1x
UBFO Unlock Forecast - 30 Days FREE Trial $159M 14.2x 1.2x
UBOH Unlock Forecast - 30 Days FREE Trial $114M 10.1x 1.4x
UMBF Unlock Forecast - 30 Days FREE Trial $8252M 16.2x 1.1x
UMBFO Unlock Forecast - 30 Days FREE Trial $2020M 3.8x 0.3x
USB Unlock Forecast - 30 Days FREE Trial $73070M 10.8x 1.2x
USB-PA Unlock Forecast - 30 Days FREE Trial $1266720M 183.6x 20.6x
USB-PH Unlock Forecast - 30 Days FREE Trial $29546M 4.3x 0.5x
USB-PP Unlock Forecast - 30 Days FREE Trial $37206M 5.4x 0.6x
USB-PQ Unlock Forecast - 30 Days FREE Trial $24659M 3.6x 0.4x
USB-PR Unlock Forecast - 30 Days FREE Trial $26208M 3.8x 0.4x
USB-PS Unlock Forecast - 30 Days FREE Trial $30436M 4.4x 0.5x
VABK Unlock Forecast - 30 Days FREE Trial $217M 12.1x 1.3x
VLY Unlock Forecast - 30 Days FREE Trial $6175M 13.6x 0.8x
VLYPN Unlock Forecast - 30 Days FREE Trial $14542M 32.1x 1.9x
VLYPO Unlock Forecast - 30 Days FREE Trial $14086M 31.1x 1.9x
VLYPP Unlock Forecast - 30 Days FREE Trial $14176M 31.3x 1.9x
VYLD Unlock Forecast - 30 Days FREE Trial $74257M 1.3x 0.2x
WABC Unlock Forecast - 30 Days FREE Trial $1229M 9.8x 1.3x
WAFD Unlock Forecast - 30 Days FREE Trial $2307M 10.3x 0.8x
WAFDP Unlock Forecast - 30 Days FREE Trial $1306M 5.8x 0.4x
WBHC Unlock Forecast - 30 Days FREE Trial $2100M 33.3x 4.0x
WBS Unlock Forecast - 30 Days FREE Trial $9455M 11.0x 1.0x
WBS-PF Unlock Forecast - 30 Days FREE Trial $3400M 4.0x 0.4x
WBS-PG Unlock Forecast - 30 Days FREE Trial $4068M 4.8x 0.4x
WFC Unlock Forecast - 30 Days FREE Trial $276922M 13.2x 1.5x
WFCNP Unlock Forecast - 30 Days FREE Trial $5824M 0.3x 0.0x
WFC-PA Unlock Forecast - 30 Days FREE Trial $63603M 3.1x 0.4x
WFC-PC Unlock Forecast - 30 Days FREE Trial $58998M 2.9x 0.3x
WFC-PD Unlock Forecast - 30 Days FREE Trial $57668M 2.8x 0.3x
WFC-PL Unlock Forecast - 30 Days FREE Trial $4015807M 195.1x 22.2x
WFC-PY Unlock Forecast - 30 Days FREE Trial $79673M 3.9x 0.4x
WFC-PZ Unlock Forecast - 30 Days FREE Trial $64311M 3.1x 0.4x
WSBC Unlock Forecast - 30 Days FREE Trial $2874M 22.2x 0.8x
WSBCP Unlock Forecast - 30 Days FREE Trial $2428M 18.0x 0.6x
WSFS Unlock Forecast - 30 Days FREE Trial $3060M 11.5x 1.1x
ZION Unlock Forecast - 30 Days FREE Trial $7603M 8.2x 1.2x
ZIONP Unlock Forecast - 30 Days FREE Trial $3221M 3.8x 0.5x

Frequently Asked Questions - CAMDEN NATIONAL CORP Stock Forecast

How accurate are CAMDEN NATIONAL CORP stock predictions?

Our AI model shows a 10% Spearman correlation coefficient for CAC predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence CAMDEN NATIONAL CORP stock price forecasts?

Our analysis considers CAMDEN NATIONAL CORP's financial metrics, Finance sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is CAMDEN NATIONAL CORP a good investment in 2025?

Based on our AI analysis, CAMDEN NATIONAL CORP shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are CAMDEN NATIONAL CORP forecasts updated?

CAMDEN NATIONAL CORP stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced CAMDEN NATIONAL CORP Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for CAMDEN NATIONAL CORP stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...